bowman-birk inhibitor
Biologicalexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 1999 (NCT00330382)
Timeline
Indications
Mechanism of action
- Tryptase beta-1INHIBITOR
TPSAB1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bowman-birk inhibitor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00679094 | Phase 1 | Jun 1, 2007 | National Cancer Institute (NCI), University of Pennsylvania |
| NCT00287833 | Phase 1 | Jan 1, 2006 | National Cancer Institute (NCI), University of Pennsylvania |
| NCT00330382 | Phase 2 | Jan 1, 1999 | National Cancer Institute (NCI), University of California, Irvine |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 3 | 2 | 1999 |
| University of Pennsylvania | Academic/Hospital | 2 | 0 | 1 | 2006 |
| University of California, Irvine | Academic/Hospital | 1 | 0 | 1 | 1999 |
3 organizations
Page 1 / 1